Molecular mechanism of poliovirus Sabin vaccine strain attenuation

被引:12
|
作者
Avanzino, Brian C. [1 ]
Jue, Helen [1 ]
Miller, Clare M. [2 ]
Cheung, Emily [2 ]
Fuchs, Gabriele [2 ]
Fraser, Christopher S. [1 ]
机构
[1] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA
[2] SUNY Albany, Dept Biol Sci, RNA Inst, Albany, NY 12222 USA
基金
美国国家卫生研究院;
关键词
poliovirus; eukaryotic translation initiation factor 4G (eIF4G); eukaryotic initiation factor 4A (eIF4A); RNA-binding protein; eukaryotic translation initiation; plus-stranded RNA virus; internal ribosome entry site (IRES); vaccine; virulence; TRACT-BINDING-PROTEIN; INTERNAL RIBOSOME ENTRY; HUMAN NEUROBLASTOMA; ATPASE ACTIVITIES; NONCODING REGION; HELICASE EIF4A; TRANSLATION; INITIATION; RNA; TYPE-3;
D O I
10.1074/jbc.RA118.004913
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recruitment of poliovirus (PV) RNA to the human ribosome requires the coordinated interaction of the viral internal ribosome entry site (IRES) and several host cellular initiation factors and IRES trans-acting factors (ITAFs). Attenuated PV Sabin strains contain point mutations in the PV IRES domain V (dV) that inhibit viral translation. Remarkably, attenuation is most apparent in cells of the central nervous system, but the molecular basis to explain this is poorly understood. The dV contains binding sites for eukaryotic initiation factor 4G (eIF4G) and polypyrimidine tract-binding protein (PTB). Impaired binding of these proteins to the mutant IRESs has been observed, but these effects have not been quantitated. We used a fluorescence anisotropy assay to reveal that the Sabin mutants reduce the equilibrium dissociation constants of eIF4G and PTB to the PV IRES by up to 6-fold. Using the most inhibitory Sabin 3 mutant, we used a real-time fluorescence helicase assay to show that the apparent affinity of an active eIF4G/4A/4B helicase complex for the IRES is reduced by 2.5-fold. The Sabin 3 mutant did not alter the maximum rate of eIF4A-dependent helicase activity, suggesting that this mutant primarily reduces the affinity, rather than activity, of the unwinding complex. To confirm this affinity model of attenuation, we show that eIF4G overexpression in HeLa cells overcomes the attenuation of a Sabin 3 mutant PV-luciferase replicon. Our study provides a quantitative framework for understanding the mechanism of PV Sabin attenuation and provides an explanation for the previously observed cell type-specific translational attenuation.
引用
收藏
页码:15471 / 15482
页数:12
相关论文
共 50 条
  • [1] Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3
    Guest, S
    Pilipenko, E
    Sharma, K
    Chumakov, K
    Roos, RP
    JOURNAL OF VIROLOGY, 2004, 78 (20) : 11097 - 11107
  • [2] GENETIC-BASIS OF ATTENUATION OF THE SABIN TYPE-2 VACCINE STRAIN OF POLIOVIRUS IN PRIMATES
    MACADAM, AJ
    POLLARD, SR
    FERGUSON, G
    SKUCE, R
    WOOD, D
    ALMOND, JW
    MINOR, PD
    VIROLOGY, 1993, 192 (01) : 18 - 26
  • [3] Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype
    Rezapkin, GV
    Fan, LJ
    Asher, DM
    Fibi, MR
    Dragunsky, EM
    Chumakov, KM
    VIROLOGY, 1999, 258 (01) : 152 - 160
  • [4] DETERMINANTS OF ATTENUATION AND TEMPERATURE SENSITIVITY IN THE TYPE-1 POLIOVIRUS SABIN VACCINE
    BOUCHARD, MJ
    LAM, DH
    RACANIELLO, VR
    JOURNAL OF VIROLOGY, 1995, 69 (08) : 4972 - 4978
  • [5] MOLECULAR AND ANTIGENIC EVOLUTION OF THE SABIN VACCINE STRAIN OF POLIOVIRUS TYPE-3 DURING THE PERIOD OF EXCRETION BY PRIMARY VACCINE
    MINOR, PD
    JOHN, A
    ICENOGLE, JP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 298 - 298
  • [6] Genetic stability of Sabin 1 strain of poliovirus: Implications for quality control of oral poliovirus vaccine
    Rezapkin, GV
    Alexander, W
    Dragunsky, E
    Parker, M
    Pomeroy, K
    Asher, DM
    Chumakov, KM
    VIROLOGY, 1998, 245 (02) : 183 - 187
  • [7] GENETIC-BASIS OF ATTENUATION OF THE SABIN TYPE-3 ORAL POLIOVIRUS VACCINE
    WESTROP, GD
    WAREHAM, KA
    EVANS, DMA
    DUNN, G
    MINOR, PD
    MAGRATH, DI
    TAFFS, F
    MARSDEN, S
    SKINNER, MA
    SCHILD, GC
    ALMOND, JW
    JOURNAL OF VIROLOGY, 1989, 63 (03) : 1338 - 1344
  • [8] STUDIES ON THE GENETIC-BASIS OF ATTENUATION OF THE SABIN TYPE-3 POLIOVIRUS VACCINE
    ALMOND, JW
    WESTROP, GD
    WAREHAM, KA
    SKINNER, MA
    EVANS, DMA
    MAGRATH, D
    SCHILD, GC
    MINOR, PD
    BIOCHEMICAL SOCIETY SYMPOSIA, 1987, (53) : 85 - 90
  • [9] Phase 3 Trial of a Sabin Strain-Based Inactivated Poliovirus Vaccine
    Liao, Guoyang
    Li, Rongcheng
    Li, Changgui
    Sun, Mingbo
    Jiang, Shude
    Li, Yanping
    Mo, Zhaojun
    Xia, Jielai
    Xie, Zhongping
    Che, Yanchun
    Yang, Jingsi
    Yin, Zhifang
    Wang, Jianfeng
    Chu, Jiayou
    Cai, Wei
    Zhou, Jian
    Wang, Junzhi
    Li, Qihan
    JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (11): : 1728 - 1734
  • [10] NATURAL VARIANTS OF THE SABIN TYPE-1 VACCINE STRAIN OF POLIOVIRUS AND CORRELATION WITH A POLIOVIRUS NEUTRALIZATION SITE
    JAMESON, BA
    BONIN, J
    WIMMER, E
    KEW, OM
    VIROLOGY, 1985, 143 (01) : 337 - 341